Klassen H (2016) Stem cells in clinical trials for retinal degeneration. Expert Opin Biol Ther 16(5):573–582

Google Scholar 

Wiley LA, Burnight ER, DeLuca AP, Anfinson KR, Cranston CM, Kaalberg EE et al (2016) Patient-specific induced pluripotent stem cells (iPSCs) for the study and treatment of retinal degenerative diseases. Prog Retin Eye Res 55:52–61

Google Scholar 

Schwartz SD, Regillo CD, Lam BL, Eliott D, Rosenfeld PJ, Gregori NZ et al (2015) Human embryonic stem cell-derived retinal pigment epithelium in patients with age-related macular degeneration and Stargardt’s macular dystrophy: follow-up of two open-label phase 1/2 studies. Lancet 385(9967):509–516

Article  PubMed  Google Scholar 

Osakada F, Takahashi M (2011) Stem cell biology and regenerative medicine for retinal pigment epithelial cells. Ophthalmologica 226(Suppl 1):57–66

Google Scholar 

Trounson A, Shepard KA, DeWitt ND (2012) Human stem cell trials for degenerative eye diseases: a perspective. Cell Stem Cell 11(1):26–35

Google Scholar 

Assawachananont J, Mandai M, Okamoto S, Yamada C, Eiraku M, Yonemura S et al (2014) Transplantation of embryonic and induced pluripotent stem cell-derived 3D retinal sheets into retinal-degenerate rats. Stem Cell Rep 2(6):662–674

Article  Google Scholar 

Meyer JS, Howden SE, Wallace KA, Verhoeven AD, Wright LS, Capowski EE et al (2011) Optic vesicle-like structures derived from human pluripotent stem cells facilitate a customized approach to retinal disease treatment. Stem Cells 29(9):1206–1218

Article  PubMed  CAS  Google Scholar 

Ohnaka M, Miki K, Kon T, Kurosawa Y, Araki R, Kawase E et al (2017) Loss of CDKN2A tumor suppressor gene promotes iPSC generation and retinoblastoma development. Stem Cell Rep 9(5):1529–1545

Google Scholar 

Jang J, Kang HC, Kim HS, Kim JY, Huh YJ, Kim DS et al (2020) Induced pluripotent stem cell models from X-linked juvenile retinoschisis patients harboring novel mutations in the RS1 gene. Exp Mol Med 52(1):15–26

Google Scholar 

Russell S, Bennett J, Wellman JA, Chung DC, Yu Z-F, Tillman A et al (2017) Efficacy and safety of voretigene neparvovec (AAV2-hRPE65v2) in patients with RPE65-mediated inherited retinal dystrophy: a randomised, controlled, open-label, phase 3 trial. Lancet 390(10097):849–860

Article  PubMed  PubMed Central  CAS  Google Scholar 

Yin C, Zhang Y, Hu J, Li X, Zhang X (2019) Advances in gene therapy for inherited retinal diseases. Sci China Life Sci 62(3):281–295

Google Scholar 

Maguire AM, Simonelli F, Pierce EA, Pugh EN Jr, Mingozzi F, Bennicelli J et al (2008) Safety and efficacy of gene transfer for Leber’s congenital amaurosis. N Engl J Med 358(21):2240–2248

Article  PubMed  PubMed Central  CAS  Google Scholar 

Arslan SZ, Pekel G, Cankurtaran V, Ozaydin B, Kurna SA (2020) Platelet-rich plasma application in ophthalmology. Ther Adv Ophthalmol 12:2515841420945151

Google Scholar 

Chiang B, Venugopal N, Edelhauser HF, Prausnitz MR (2021) Suprachoroidal drug delivery for nonviral ocular gene therapy. Transl Vis Sci Technol 10(2):26

Google Scholar 

Alio JL, Arnalich-Montiel F, Rodriguez AE (2012) The role of “eye platelet-rich plasma” (E-PRP) for wound healing in ophthalmology. Curr Pharm Biotechnol 13(7):1257–1265

Article  PubMed  CAS  Google Scholar 

Mandai M, Fujii M, Hashiguchi T, Sunagawa GA, Ito S, Sun J et al (2017) iPSC-derived retinal transplants improve vision in rd1 end-stage retinal degeneration mice. Stem Cell Rep 8(1):69–83

Article  Google Scholar 

Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372:n171. https://doi.org/10.1136/bmj.N71

Article  Google Scholar 

Sterne JAC, Savović J, Page MJ, Elbers RG, Blencowe NS, Boutron I, Cates CJ, Cheng H-Y, Corbett MS, Eldridge SM, Hernán MA, Hopewell S, Hróbjartsson A, Junqueira DR, Jüni P, Kirkham JJ, Lasserson T, Li T, McAleenan A, Reeves BC, Shepperd S, Shrier I, Stewart LA, Tilling K, White IR, Whiting PF, Higgins JPT (2019) RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ 366:l4898

Article  PubMed  Google Scholar 

Schwarzer G (2024) Meta: general package for meta-analysis. Version 7.0-0. R Foundation for Statistical Computing. https://github.com/guido-s/meta/

Özmert E, Arslan U (2020) Management of retinitis pigmentosa by Wharton’s jelly-derived mesenchymal stem cells: prospective analysis of 1-year results. Stem Cell Res Ther 11:353

Article  PubMed  PubMed Central  Google Scholar 

Zhao T, Liang Q, Meng X, Duan P, Wang F, Li S et al (2020) Intravenous infusion of umbilical cord mesenchymal stem cells maintains and partially improves visual function in patients with advanced retinitis pigmentosa. Stem Cells Dev 29(16):1029–1037. https://doi.org/10.1089/scd.2020.0037

Article  PubMed  CAS  Google Scholar 

Kahraman NS, Oner A (2020) Umbilical cord derived mesenchymal stem cell implantation in retinitis pigmentosa: a 6-month follow-up results of a phase 3 trial. Int J Ophthalmol 13(9):1423–1429. https://doi.org/10.18240/ijo.2020.09.14

Article  PubMed  PubMed Central  Google Scholar 

Tuekprakhon A, Sangkitporn S, Trinavarat A, Pawestri AR, Vamvanij V, Ruangchainikom M et al (2021) Intravitreal autologous mesenchymal stem cell transplantation: a non-randomized phase I clinical trial in patients with retinitis pigmentosa. Stem Cell Res Ther 12(1):52. https://doi.org/10.1186/s13287-020-02122-7

Article  PubMed  PubMed Central  CAS  Google Scholar 

Limoli PG, Limoli CSS, Morales MU (2020) Mesenchymal stem cell surgery, rescue and regeneration in retinitis pigmentosa: clinical and rehabilitative prognostic aspects. Restor Neurol Neurosci 38(3):223–237. https://doi.org/10.3233/RNN-190970

Article  PubMed  PubMed Central  CAS  Google Scholar 

Zhu Y, Huang C, Zheng L, Li Q, Ge J, Geng S et al (2024) Safety and efficacy of umbilical cord tissue-derived mesenchymal stem cells in the treatment of patients with aging frailty: a phase I/II randomized, double-blind, placebo-controlled study. Stem Cell Res Ther 29(15):122. https://doi.org/10.1186/s13287-024-03707-2

Article  CAS  Google Scholar 

Maguire AM, Russell S, Wellman JA, Chung DC, Yu ZF, Tillman A et al (2019) Efficacy, safety, and durability of voretigene neparvovec-rzyl in RPE65 mutation-associated inherited retinal dystrophy: results of phase 1 and 3 trials. Ophthalmology 126(9):1273–1285. https://doi.org/10.1016/j.ophtha.2019.06.017

Article  PubMed  Google Scholar 

Cehajic-Kapetanovic J, Xue K, Martinez-Fernandez de la Camara C, Nanda A, Davies A, Wood LJ et al (2020) Initial results from a first-in-human gene therapy trial on X-linked retinitis pigmentosa caused by mutations in RPGR. Nat Med 26(3):354–359. https://doi.org/10.1038/s41591-020-0763-1

Article  PubMed  PubMed Central  CAS  Google Scholar 

Hoffman DR, Wheaton DK, Fish GE, Spencer R, Pearson NS, Takacs A, Klein M, Locke KG, Birch DG (2014) High dose docosahexaenoic acid (DHA) supplementation in X-linked retinitis pigmentosa (XLRP): a 4-year randomized, controlled clinical trial. In: ARVO annual meeting abstract

Hoffman DR, Locke KG, Wheaton DH, Fish GE, Spencer R, Birch DG (2004) A randomized, placebo-controlled clinical trial of docosahexaenoic acid supplementation for X-linked retinitis pigmentosa. Am J Ophthalmol 137(4):704–718. https://doi.org/10.1016/j.ajo.2003.10.045

Article  PubMed  CAS  Google Scholar 

Birch DG, Bennett LD, Duncan JL, Weleber RG, Pennesi ME (2016) Long-term follow-up of patients with retinitis pigmentosa receiving intraocular ciliary neurotrophic factor implants. Am J Ophthalmol 170:10–14. https://doi.org/10.1016/j.ajo.2016.07.013

Article  PubMed  PubMed Central  Google Scholar 

Li L, Zhang X, Chen M, Wang D, Zhou H, Liu Y et al (2023) Mesenchymal stem cell-derived neurotrophic factors promote photoreceptor survival in retinal degeneration. Stem Cell Res Ther 14(1):1–15

Google Scholar 

Zhang W, Wang Y, Kong J, Liu R, Yang H, Chen X et al (2022) BDNF-expressing mesenchymal stem cells protect retinal neurons through paracrine effects. Cell Transplant 31:963689721989266

Google Scholar 

Chen M, Liu Y, Li W, Zhang H, Zhang L, Wang S et al (2023) Mesenchymal stem cells modulate retinal microenvironment through paracrine signaling in retinitis pigmentosa. Mol Ther 31(1):44–58

Google Scholar 

Wang S, Liu R, Yang H, Li X, Zhang L, Chen X et al (2022) Antioxidant and anti-inflammatory properties of mesenchymal stem cells in retinal disease. Prog Retin Eye Res 86:100971

Google Scholar 

Liu Y, Zhang H, Li W, Chen M, Wang D, Zhou H et al (2023) Transcriptomic analysis of mesenchymal stem cell differentiation into retinal lineages. Stem Cell Rep 18(4):825–839

CAS  Google Scholar 

Park SS, Moisseiev E, Bauer G, Anderson JD, Grant MB, Zam A et al (2022) Integration and survival of transplanted mesenchymal stem cells in degenerative retina. Invest Ophthalmol Vis Sci 63(3):23

Google Scholar 

Kim JY, Park J, Lee JH, Kim HJ, Park SS, Lee SJ et al (2023) Immunomodulatory effects of mesenchymal stem cells in retinal disorders. Front Immunol 14:1123847

Google Scholar 

Huang Y, Liu R, Yang H, Wang S, Zhang L, Chen X et al (2022) Mesenchymal stem cell-mediated tissue repair in retinitis pigmentosa: mechanisms and therapeutic potential. Stem Cells Int 2022:9847563

Google Scholar 

Thompson DA, Ali RR, Banin E, Brankov M, Flannery JG, Gamm DM et al (2023) Advances in cell delivery strategies for retinal cell therapy. Nat Rev Drug Discov 22(1):55–74

Google Scholar 

Lee JH, Kim HJ, Park J, Kim JY, Park SS, Lee SJ et al (2022) Optimization of mesenchymal stem cell delivery for retinal diseases. Biomaterials 280:121272